Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Tempus AI's valuation drops amid profitability concerns, offering a buying opportunity as data revenues surge 70%.
TEM
$57.08
-$0.17 -0.30%

Tempus AI's valuation drops amid profitability concerns, offering a buying opportunity as data revenues surge 70%.

Market News
22 May 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Tempus AI, a leader in precision medicine using AI, has seen its share price fall due to concerns about profitability, creating an attractive entry point for investors willing to take risks. The company reported a nearly 70% increase in data licensing revenues last quarter, driven by AI products and foundation models that support high-margin growth. Management forecasts a 25% compound annual growth rate and expects profitability to accelerate by 2026 as its data business scales. This positions Tempus AI as a competitive player with significant partnerships and a contract backlog exceeding $1 billion.

More News (TEM)

Tempus AI's healthcare data segment revenue jumps 40% YoY, targeting $500M+ in 2026.

Tempus AI's healthcare data segment revenue jumps 40% YoY, targeting $500M+ in 2026.

Tempus AI, Inc. reported a 40% year-over-year increase in its healthcare data segment revenue for Q1 2026, reaching $87 million. This growth is driven by a surge in MRD testing volume, which rose 500% YoY due to a partnership with Personalis for a re...

Analyst Insights
Bullish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App